NCT06732427View on ClinicalTrials.gov

Clinical Study of Fospropofol Disodium for Injection in the Painless Endoscopic Diagnosis and Treatment

NARecruitingINTERVENTIONAL
Enrollment

426

Participants

Timeline

Start Date

August 12, 2025

Primary Completion Date

June 30, 2026

Study Completion Date

December 31, 2026

Conditions
Efficacy and Safety
Interventions
DRUG

fospropofol Disodium for injection

Group L received slow intravenous sufentanyl 0. 1 ug / kg +fospropofol Disodium for injection 8mg / kg (completed within 60 seconds)

DRUG

Propofol

Group B received slow intravenous sufentanyl 0. 1 ug / kg +propofol 2mg / kg (completed within 60 seconds)

Trial Locations (5)

226001

RECRUITING

Affiliated Hospital of Nantong University, Nantong

226200

NOT_YET_RECRUITING

Qidong People's Hospital, Qidong

226400

RECRUITING

Rudong County Hospital of Traditional Chinese Medicine, Rudong

226500

RECRUITING

Rugao People's Hospital, Rugao

226600

RECRUITING

Hai 'an People's Hospital, Hai’an

All Listed Sponsors
collaborator

Rugao People's Hospital

OTHER

collaborator

Qidong People's Hospital

UNKNOWN

collaborator

Hai 'an People's Hospital

UNKNOWN

collaborator

Rudong County Hospital of Traditional Chinese Medicine

UNKNOWN

lead

Affiliated Hospital of Nantong University

OTHER

NCT06732427 - Clinical Study of Fospropofol Disodium for Injection in the Painless Endoscopic Diagnosis and Treatment | Biotech Hunter | Biotech Hunter